UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,022,456 | -54.5% | 152,378 | +36.6% | 0.00% | -94.1% |
| Q1 2023 | $2,246,456 | +271.9% | 111,542 | +246.4% | 0.03% | +183.3% |
| Q3 2022 | $604,000 | +46.2% | 32,196 | +45.5% | 0.01% | +9.1% |
| Q2 2022 | $413,000 | +16.7% | 22,130 | +12.9% | 0.01% | +22.2% |
| Q1 2022 | $354,000 | +71.8% | 19,599 | +351.5% | 0.01% | -80.0% |
| Q1 2020 | $206,000 | -17.9% | 4,341 | +24.0% | 0.04% | +164.7% |
| Q4 2019 | $251,000 | -7.4% | 3,500 | -49.3% | 0.02% | +6.2% |
| Q3 2019 | $271,000 | -77.0% | 6,900 | -54.3% | 0.02% | -87.6% |
| Q2 2019 | $1,179,000 | +266.1% | 15,101 | +179.4% | 0.13% | +138.9% |
| Q1 2019 | $322,000 | – | 5,405 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |